F 0554
Allow residents to self-administer drugs if determined clinically appropriate.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review, the facility failed to follow their facility policy, and ensure that a
resident had a physician order for medications that were stored at the bedside along with an assessment
for self-administration of medications for two of four residents (R2 and R3) reviewed for self-administration
of medication in a sample of four.
Residents Affected - Few
Findings include:
The facility's Self-Administration of Medication Policy dated 8/2017 documents it is the responsibility of the
Interdisciplinary Team/IDT to assess and determine if those residents who request to self-medicate can do
so. This same policy states, Procedure: A resident may not be permitted to administer or retain any
medication in his/her room unless so ordered by the physician. 2. Should the resident's attending physician
permit the resident to administer his/her medications, the following conditions will apply: A. The IDT will
evaluate the resident's cognitive, physical, and visual ability to self-medicate using the Assessment Form
for Self-Administration of Medications. B. The Care Plan will reflect the program of each resident. C. Storage
of medication may be in the resident's room or in the locked medication cart. D. Only the medications
permitted for self-administration shall be left at the bedside.
1. R2's Medication Review Report documents R2 with a diagnosis of Chronic Obstructive Pulmonary
Disease/COPD and an order with a start date of 7/17/23 for Symbicort Inhalation Aerosol 160-4.5
MCG/ACT (Micrograms per Actuation). Two puffs inhale orally two times a day for COPD.
R2's Minimum Data Set/MDS assessment dated [DATE] documents R2 as cognitively intact.
On 9/14/23 at 1:04 PM, R2 was sitting up in R2's bed with oxygen via nasal cannula in place. R2 was alert
and able to answer questions well. R2's bedside table was pulled across the bed in front of R2. Lying on top
of the bedside table was R2's Symbicort inhaler. At this time, R2 stated that R2 keeps R2's Symbicort
inhaler in R2's room so that R2 can use the inhaler when needed. R2 stated R2 has always kept his inhaler
in R2's room and that R2 notifies the nursing staff when R2 uses R2's inhaler. R2 stated R2 has COPD and
stated the Symbicort Inhaler helps R2 breathe better.
As of 9/14/23 at 1:00 PM, R2's medical records did not contain a physician order for R2 to keep
medications at R2's bedside and did not contain an assessment for self-administration of medications. R2's
Care Plan did not contain documentation regarding R2's ability to self-administer medications or to keep
medications at R2's bedside.
On 9/14/23 at 1:46 PM, V2 (Director of Nursing) verified the presence of R2's Symbicort Inhaler in
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
145039
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145039
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/15/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Accolade Healthcare of Peoria
5600 Glen Elm Drive
Peoria, IL 61614
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0554
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
R2's room on R2's bedside table. At this time, V2 informed R2 that R2 would need a physician order to
continue to keep R2's inhaler at the bedside. R2 verbalized understanding.
On 9/14/23 at 1:55 PM, V2 verified that R2 did not have a physician order for medications to be left at R2's
bedside and that R2 did not have an assessment completed for self-administration of medications prior to
9/14/23. V2 stated V2 would get those now.
2. R3's Medication Review Report documents R3 with diagnoses of Chronic Obstructive Pulmonary
Disease/COPD and Asthma. This same report documents orders for the following: Symbicort Inhalation
Aerosol 160-4.5 MCG/ACT (Micrograms per Actuation). Two puffs inhale orally two times a day for COPD
with an order start date of 5/14/23: Spiriva Respimat Inhalation Aerosol Solution 2/5 MCG/ACT. Two puff
inhale orally one time a day for COPD with an order start date of 5/10/23; and Fluticasone Propionate
Nasal Suspension 50 MCG/ACT. Two sprays in both nostrils one time a day for congestion with an order
start date of 5/10/23.
R3's Minimum Data Set/MDS assessment dated [DATE] documents R3 as cognitively intact.
On 9/14/23 at 1:30 PM, R3 sitting up in bed in R3's room. R3 was alert and able to answer questions well.
A bedside table was positioned to the left of R3's bed with a nightstand table directly behind the bedside
table positioned against the wall. Lying on top the table were two inhalers and a bottle of nasal spray. At this
time, R3 stated, That's my Symbicort and my Spiriva. I keep those here in my room and use them when I
need to because I am with it. I know that I use my Symbicort twice a day and my Spiriva as a rescue inhaler
once a day. I do the nasal spray myself too. I've always kept these here in my room.
On 9/14/23 at 1:51 PM, V2 (Director of Nursing) verified the presence of R3's Symbicort and Spiriva
Inhalers and R3's Nasal Spray in R3's room. At this time, V2 informed R3 that R3 would need a physician
order to continue to keep R3's inhalers and nasal spray at R3's bedside. R3 stated, You better not take
these from me. Upon V2's exit for R3's room, V2 left the medications in R3's room.
As of 9/14/23 at 1:00 PM, R3's medical records did not contain a physician order for R3 to keep
medications at R3's bedside and did not contain an assessment for self-administration of medications. R3's
Care Plan did not contain documentation regarding R3's ability to self-administer medications or to keep
medications at R3's bedside.
On 9/14/23 at 1:55 PM, V2 verified that R3 did not have a physician order for medications to be left at R3's
bedside and that R3 did not have an assessment completed for self-administration of medications prior to
9/14/23. V2 stated V2 would get those now.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145039
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145039
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/15/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Accolade Healthcare of Peoria
5600 Glen Elm Drive
Peoria, IL 61614
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to follow its policy and obtain initial wound measurements,
obtain physician orders for treatment of a skin impairment and to ensure a wound was monitored for one of
three residents (R1) reviewed for wounds in the sample of four.
Residents Affected - Few
Findings include:
The facility's Skin and Wound Management Guidelines dated 4/2023 states, The facility will initiate
aggressive wound management for those residents who have pressure injuries, vascular or diabetic
wounds, surgical wounds, etc. This same policy documents for residents who have a wound on admission,
the staff/licensed nurse will ensure there is a treatment order in place to include: wound site, how the area
will be cleansed, type of treatment, frequency of treatment/dressing change, and periwound orders if
needed. This same policy states, Wound Care Nurse: Review new admissions and readmissions and
assess, measure, photograph, and document in Wound Rounds on any wound identified. This includes
Stage I, significant skin tears, rashes, and bruising. 3. Ensure the treatment order is in place and
appropriate. 4. Initiate Care Plan for identified wounds.
R1's admission Record documents R1 was admitted to the facility on [DATE] with diagnoses to include but
not limited to: Left ankle/foot Osteomyelitis; End Stage Renal Disease with Dependence on Renal Dialysis;
Type II Diabetes Mellitus; Morbid Obesity; and Anemia.
R1's Hospital History and Physical (H&P) dated 6/17/23 documents an MRI/Magnetic Resonance Imaging
of the left forefoot/midfoot with and without contrast on 6/9/23. This MRI documents an impression of soft
tissue edema and marrow signal abnormality with periostitis within the proximal and middle phalanges of
the fourth toe which may reflect reactive osteitis or early osteomyelitis. The probability of osteomyelitis
increases if there is associated skin ulceration This same H&P states, Chronic left fourth toe diabetic
ulcer/wound infection with early osteomyelitis evaluated by the podiatrist during the recent admission and
continue the IV (Intravenous) Cefepime and Vancomycin post hemodialysis per ID (Infectious Disease)
recommendations.
R1's SNF (Skilled Nursing Facility) History and Physical dated 7/13/23 documents R1's Principal Problem:
Left Fourth Toe Osteomyelitis. This same form documents R1 is currently being treated with antibiotics for
R1's left fourth toe osteomyelitis due to stop 7/20/23.
R1's Admission/readmission Nursing Assessment signed and dated 7/11/23 by V3 (Assistant Director of
Nursing) documents a left fourth toe scab.
R1's admission Skin assessment dated [DATE] and completed by V4 (Wound Nurse) does not document
R1's left fourth toe scab or any measurements of the area.
R1's Weekly Skin Assessments on the following dates do not contain any documentation regarding R1's left
fourth toe wound: 7/18/23; 7/25/23; 8/1/23; or 8/8/23.
R1's Skin/Wound Note on 8/11/23 at 7:23 AM signed by V4 (Wound Nurse) documents R1 has a scab
noted to R1's left (fourth) toe measuring 2 (centimeters/cm) by 1.2 cm with no exudate, foam border
applied, and wound physician will follow next visit. On 9/14/23 at 11:54 AM, V4 verified R1's wound was on
the left fourth toe and was incorrectly documented as the third toe.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145039
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145039
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/15/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Accolade Healthcare of Peoria
5600 Glen Elm Drive
Peoria, IL 61614
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
R1's Initial Wound Evaluation and Management Summary signed and dated By V5 (Wound Physician) on
8/15/23 documents R1 with a diabetic wound to the left fourth toe for a duration of greater than 36 days
measuring 1.1 cm by 1.1 cm. Betadine paint once daily treatments were ordered.
On 9/14/23 at 11:54 AM, V4 (Wound Nurse) verified that wound measurements were not obtained upon
R1's admission to the facility and wound treatments were not initiated for R1's left fourth toe wound until
8/11/23. V4 stated that V4 was not aware R1's wound was a healing diabetic foot ulcer with a history of
osteomyelitis. V4 denied being aware that R1 admitted to the facility with physician orders for intravenous
antibiotics for treatment of osteomyelitis of R1's left fourth toe. V4 stated R1's wound should have been
assessed weekly including wound measurements and the physician should have been contacted for
treatment orders. V4 stated, It was just a scab. We don't usually measure scabs. V4 stated V4 contacted V5
(Wound Physician) when R1's wound was assessed to have changed color and size.
R1's medical record did not contain documentation that R1's left fourth toe wound was measured or
monitored upon admission or weekly thereafter until 8/11/23. R1's medical record did not contain
documentation that treatment orders for R1's left fourth toe were initiated prior to 8/11/23.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145039
If continuation sheet
Page 4 of 4